Resultats de la cerca - David Roberge

Refinar resultats
  1. 1
    Local Recurrence After Initial Multidisciplinary Management of Soft Tissue Sarcoma: Is there a Way Out?

    Local Recurrence After Initial Multidisciplinary Management of Soft Tissue Sarcoma: Is there a Way Out? per Sarantis Abatzoglou, Robert Turcotte, Abdurahman Adoubali, Marc Isler, David Roberge

    Publicat 2010
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  2. 2
    FDG PET/CT in Initial Staging of Adult Soft-Tissue Sarcoma

    FDG PET/CT in Initial Staging of Adult Soft-Tissue Sarcoma per David Roberge, Siavosh Vakilian, Yazan Z. Alabed, Robert Turcotte, Carolyn Freeman, Marc Hickeson

    Publicat 2012
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  3. 3
    Treatment of Brain AVMs (TOBAS): study protocol for a pragmatic randomized controlled trial

    Treatment of Brain AVMs (TOBAS): study protocol for a pragmatic randomized controlled trial per Tim E. Darsaut, Elsa Magro, Jean‐Christophe Gentric, André Lima Batista, Chiraz Chaalala, David Roberge, Michel W. Bojanowski, Alain Weill, Daniel Roy, Jean Raymond

    Publicat 2015
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  4. 4
    A combined analysis of outcome following breast cancer: differences in survival based on BRCA1/BRCA2 mutation status and administration of adjuvant treatment

    A combined analysis of outcome following breast cancer: differences in survival based on BRCA1/BRCA2 mutation status and administration of adjuvant treatment per Mark E. Robson, Pierre O. Chappuis, Jaya M. Satagopan, Nora Wong, Jeff Boyd, John R. Goffin, Clifford A. Hudis, David Roberge, Larry Norton, Louis R. Bégin, Kenneth Offit, William D. Foulkes

    Publicat 2003
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  5. 5
    Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: a randomized, double-blind, placebo-controlled trial

    Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: a randomized, double-blind, placebo-controlled trial per Paul D. Brown, S. Pugh, Nadia N. Laack, Jeffrey S. Wefel, Deepak Khuntia, Christina Meyers, Ali Choucair, Sherry Fox, John H. Suh, David Roberge, Vivek S. Kavadi, Søren M. Bentzen, Minesh P. Mehta, Deborah Watkins Bruner

    Publicat 2013
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  6. 6
    RTOG Sarcoma Radiation Oncologists Reach Consensus on Gross Tumor Volume and Clinical Target Volume on Computed Tomographic Images for Preoperative Radiotherapy of Primary Soft Tissue Sarcoma of Extremity in Radiation Therapy Oncology Group Studies

    RTOG Sarcoma Radiation Oncologists Reach Consensus on Gross Tumor Volume and Clinical Target Volume on Computed Tomographic Images for Preoperative Radiotherapy of Primary Soft Tis... per Dian Wang, Walter Bosch, David Roberge, Steven E. Finkelstein, Ivy A. Petersen, Michael G. Haddock, Yen-Lin E. Chen, Naoyuki G. Saito, David G. Kirsch, Ying J. Hitchcock, Aaron H. Wolfson, Thomas F. DeLaney

    Publicat 2011
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  7. 7
    Multidisciplinary patient-centered management of brain metastases and future directions

    Multidisciplinary patient-centered management of brain metastases and future directions per Joshua D. Palmer, Daniel M. Trifiletti, Vinai Gondi, Michael D. Chan, Giuseppe Minniti, Chad G. Rusthoven, Steven E. Schild, Mark V. Mishra, Joseph Bovi, Nicole Williams, Maryam B. Lustberg, Paul D. Brown, Ganesh Rao, David Roberge

    Publicat 2020
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  8. 8
    Canadian Expert Consensus Recommendations for the Diagnosis and Management of Glioblastoma: Results of a Delphi Study

    Canadian Expert Consensus Recommendations for the Diagnosis and Management of Glioblastoma: Results of a Delphi Study per Warren Mason, Rebecca A. Harrison, Sarah Lapointe, Mary Jane Lim-Fat, Mary MacNeil, David Mathieu, James Perry, Marshall Pitz, David Roberge, Derek S. Tsang, Christina Tsien, Frank K.H. van Landeghem, Gelareh Zadeh, Jacob C. Easaw

    Publicat 2025
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  9. 9
    LINAC based stereotactic radiosurgery for multiple brain metastases: guidance for clinical implementation

    LINAC based stereotactic radiosurgery for multiple brain metastases: guidance for clinical implementation per Dianne Hartgerink, Ans Swinnen, David Roberge, Alan Nichol, Piotr Zygmanski, F Yin, F DeBlois, Coen Hurkmans, Chin Loon Ong, A. Bruynzeel, Ayal A. Aizer, John B. Fiveash, John Kirckpatrick, Matthias Gückenberger, Nicolaus Andratschke, Dirk De Ruysscher, Richard A. Popple, Jaap Zindler

    Publicat 2019
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  10. 10
    Canadian Consensus: Oligoprogressive, Pseudoprogressive, and Oligometastatic Non-Small-Cell Lung Cancer

    Canadian Consensus: Oligoprogressive, Pseudoprogressive, and Oligometastatic Non-Small-Cell Lung Cancer per Scott A. Laurie, Shantanu Banerji, Normand Blais, Stephanie Yasmin Brule, Parneet Cheema, Patrick Cheung, Nathalie Daaboul, Desirée Hao, Vera Hirsh, Rosalyn A. Juergens, Janessa Laskin, Natasha B. Leighl, Robert M. MacRae, Garth Nicholas, David Roberge, J. Rothenstein, David J. Stewart, Ming‐Sound Tsao

    Publicat 2019
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  11. 11
    Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C/CEC·3): a multicentre, randomised, controlled, phase 3 trial

    Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C/CEC·3): a multicentre, randomised, controlled, pha... per Paul D. Brown, Karla V. Ballman, Jane H. Cerhan, S. Keith Anderson, Xiomara W. Carrero, Anthony Whitton, Jeffrey Greenspoon, Ian F. Parney, Nadia N. Laack, Jonathan B. Ashman, Jean-Paul Bahary, Costas G. Hadjipanayis, James J. Urbanic, Fred G. Barker, Elana Farace, Deepak Khuntia, Caterina Giannini, Jan C. Buckner, Evanthia Galanis, David Roberge

    Publicat 2017
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  12. 12
    Summary Report on the Graded Prognostic Assessment: An Accurate and Facile Diagnosis-Specific Tool to Estimate Survival for Patients With Brain Metastases

    Summary Report on the Graded Prognostic Assessment: An Accurate and Facile Diagnosis-Specific Tool to Estimate Survival for Patients With Brain Metastases per Paul W. Sperduto, Norbert Kased, David Roberge, Zhiyuan Xu, Ryan Shanley, Xianghua Luo, Penny K. Sneed, Samuel T. Chao, Robert J. Weil, John H. Suh, Amit Bhatt, Ashley W. Jensen, Paul D. Brown, Helen A. Shih, John P. Kirkpatrick, Laurie E. Gaspar, John B. Fiveash, Veronica Chiang, Jonathan Knisely, Christina Maria Sperduto, Nancy U. Lin, Minesh P. Mehta

    Publicat 2011
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  13. 13
    Effect of Tumor Subtype on Survival and the Graded Prognostic Assessment for Patients With Breast Cancer and Brain Metastases

    Effect of Tumor Subtype on Survival and the Graded Prognostic Assessment for Patients With Breast Cancer and Brain Metastases per Paul W. Sperduto, Norbert Kased, David Roberge, Zhiyuan Xu, Ryan Shanley, Xianghua Luo, Penny K. Sneed, Samuel T. Chao, Robert J. Weil, John H. Suh, Amit Bhatt, Ashley W. Jensen, Paul D. Brown, Helen A. Shih, John P. Kirkpatrick, Laurie E. Gaspar, John B. Fiveash, Veronica Chiang, Jonathan Knisely, Christina Maria Sperduto, Nancy U. Lin, Minesh P. Mehta

    Publicat 2011
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  14. 14
    The Prognostic Value of BRAF , C-KIT , and NRAS Mutations in Melanoma Patients With Brain Metastases

    The Prognostic Value of BRAF , C-KIT , and NRAS Mutations in Melanoma Patients With Brain Metastases per Paul W. Sperduto, Wen Jiang, Paul D. Brown, Steve Braunstein, Penny K. Sneed, Daniel A. Wattson, Helen A. Shih, Ananta Bangdiwala, Ryan Shanley, Natalie A. Lockney, Kathryn Beal, Emil Lou, Thomas Amatruda, William Sperduto, John P. Kirkpatrick, Norman Yeh, Laurie E. Gaspar, Jason K. Molitoris, Laura Masucci, David Roberge, James B. Yu, Veronica Chiang, Minesh P. Mehta

    Publicat 2017
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  15. 15
    Estimating Survival in Melanoma Patients With Brain Metastases: An Update of the Graded Prognostic Assessment for Melanoma Using Molecular Markers (Melanoma-molGPA)

    Estimating Survival in Melanoma Patients With Brain Metastases: An Update of the Graded Prognostic Assessment for Melanoma Using Molecular Markers (Melanoma-molGPA) per Paul W. Sperduto, Wen Jiang, Paul D. Brown, Steve Braunstein, Penny K. Sneed, Daniel A. Wattson, Helen A. Shih, Ananta Bangdiwala, Ryan Shanley, Natalie A. Lockney, Kathryn Beal, Emil Lou, Thomas Amatruda, William Sperduto, John P. Kirkpatrick, Norman Yeh, Laurie E. Gaspar, Jason K. Molitoris, Laura Masucci, David Roberge, James B. Yu, Veronica Chiang, Minesh P. Mehta

    Publicat 2017
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  16. 16
    Association of Long-term Outcomes With Stereotactic Radiosurgery vs Whole-Brain Radiotherapy for Resected Brain Metastasis

    Association of Long-term Outcomes With Stereotactic Radiosurgery vs Whole-Brain Radiotherapy for Resected Brain Metastasis per Joshua D. Palmer, Brett Klamer, Karla V. Ballman, Paul D. Brown, Jane H. Cerhan, S. Keith Anderson, Xiomara W. Carrero, Anthony Whitton, Jeffrey Greenspoon, Ian F. Parney, Nadia N. Laack, Jonathan B. Ashman, Jean-Paul Bahary, Costas G. Hadjipanayis, James J. Urbanic, Fred G. Barker, Elana Farace, Deepak Khuntia, Caterina Giannini, Jan C. Buckner, Evanthia Galanis, David Roberge

    Publicat 2022
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  17. 17
    The Effect of Gene Alterations and Tyrosine Kinase Inhibition on Survival and Cause of Death in Patients With Adenocarcinoma of the Lung and Brain Metastases

    The Effect of Gene Alterations and Tyrosine Kinase Inhibition on Survival and Cause of Death in Patients With Adenocarcinoma of the Lung and Brain Metastases per Paul W. Sperduto, T. Jonathan Yang, Kathryn Beal, Hubert Y. Pan, Paul D. Brown, Ananta Bangdiwala, Ryan Shanley, Norman Yeh, Laurie E. Gaspar, Steve Braunstein, Penny K. Sneed, John Boyle, John P. Kirkpatrick, Kimberley S. Mak, Helen A. Shih, Alex Engelman, David Roberge, Nils D. Arvold, Brian M. Alexander, Mark M. Awad, Joseph N. Contessa, Veronica Chiang, J. Hardie, J. Daniel, Emil Lou, William Sperduto, Minesh P. Mehta

    Publicat 2016
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  18. 18
    Estimating Survival in Patients With Lung Cancer and Brain Metastases

    Estimating Survival in Patients With Lung Cancer and Brain Metastases per Paul W. Sperduto, T. Jonathan Yang, Kathryn Beal, Hubert Y. Pan, Paul D. Brown, Ananta Bangdiwala, Ryan Shanley, Norman Yeh, Laurie E. Gaspar, Steve Braunstein, Penny K. Sneed, John Boyle, John P. Kirkpatrick, Kimberley S. Mak, Helen A. Shih, Alex Engelman, David Roberge, Nils D. Arvold, Brian M. Alexander, Mark M. Awad, Joseph N. Contessa, Veronica Chiang, J. Hardie, J. Daniel, Emil Lou, William Sperduto, Minesh P. Mehta

    Publicat 2016
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  19. 19
    Estimating survival for renal cell carcinoma patients with brain metastases: an update of the Renal Graded Prognostic Assessment tool

    Estimating survival for renal cell carcinoma patients with brain metastases: an update of the Renal Graded Prognostic Assessment tool per Paul W. Sperduto, Brian J. Deegan, Jing Li, Krishan R. Jethwa, Paul D. Brown, Natalie A. Lockney, Kathryn Beal, Nitesh Rana, Albert Attia, Chia‐Lin Tseng, Arjun Sahgal, Ryan Shanley, William Sperduto, Emil Lou, Amir Zahra, John M. Buatti, James B. Yu, Veronica Chiang, Jason K. Molitoris, Laura Masucci, David Roberge, Diana D. Shi, Helen A. Shih, Adam C. Olson, John P. Kirkpatrick, Steve Braunstein, Penny K. Sneed, Minesh P. Mehta

    Publicat 2018
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  20. 20
    Hippocampal Avoidance During Whole-Brain Radiotherapy Plus Memantine for Patients With Brain Metastases: Phase III Trial NRG Oncology CC001

    Hippocampal Avoidance During Whole-Brain Radiotherapy Plus Memantine for Patients With Brain Metastases: Phase III Trial NRG Oncology CC001 per Paul D. Brown, Vinai Gondi, Stephanie L. Pugh, Wolfgang A. Tomé, Jeffrey S. Wefel, Terri S. Armstrong, Joseph Bovi, Clifford G. Robinson, André Konski, Deepak Khuntia, David R. Grosshans, Tammie L.S. Benzinger, Deborah Watkins Bruner, Mark R. Gilbert, David Roberge, Vijayananda Kundapur, Kiran Devisetty, Sunjay Shah, Kenneth Y. Usuki, Bethany Anderson, Baldassarre Stea, Harold Yoon, Jing Li, Nadia N. Laack, Tim J. Kruser, Steven J. Chmura, Wenyin Shi, Snehal Deshmukh, Minesh P. Mehta, Lisa A. Kachnic

    Publicat 2020
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:

Eines de cerca: